We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+8.73%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$1.25B
AUM Growth
+$53.9M
Cap. Flow
-$10.8M
Cap. Flow %
-0.87%
Top 10 Hldgs %
26.05%
Holding
317
New
17
Increased
127
Reduced
146
Closed
10

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$14.2M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$5.55M
3
AMZN icon
Amazon
AMZN
+$1.99M
4
AAPL icon
Apple
AAPL
+$1.82M
5
MZTI
The Marzetti Company
MZTI
+$960K

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.38%
2 Technology 17.31%
3 Healthcare 12.84%
4 Consumer Staples 10.16%
5 Financials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIO icon
301
Fortress Biotech
FBIO
$92.4M
$81K 0.01%
1,333
BMY.RT
302
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$58K ﹤0.01%
25,979
-2,145
-8% -$6.13K
BCRX icon
303
BioCryst Pharmaceuticals
BCRX
$2.51B
$55K ﹤0.01%
16,000
+5,000
+45% +$21.4K
ADMS
304
DELISTED
Adamas Pharmaceuticals
ADMS
$54K ﹤0.01%
13,000
YELL
305
DELISTED
Yellow Corporation Common Stock
YELL
$39K ﹤0.01%
+10,000
New +$36.6K
PANA.WS
306
DELISTED
Panacea Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class
PANA.WS
$26K ﹤0.01%
+11,063
New +$27.6K
RGLS
307
DELISTED
Regulus Therapeutics
RGLS
$6K ﹤0.01%
1,200
ATNM icon
308
Actinium Pharmaceuticals
ATNM
$31.7M
-762
Closed -$8K
EFA icon
309
CALL
iShares MSCI EAFE ETF
EFA
$79.6B
-25,000
Closed -$1.52M
EFA icon
310
PUT
iShares MSCI EAFE ETF
EFA
$79.6B
-80,000
Closed -$4.87M
EOG icon
311
EOG Resources
EOG
$75.2B
-4,722
Closed -$239K
FTSM icon
312
First Trust Enhanced Short Maturity ETF
FTSM
$6.53B
-9,663
Closed -$580K
IVE icon
313
iShares S&P 500 Value ETF
IVE
$50.2B
-1,850
Closed -$200K
IWM icon
314
CALL
iShares Russell 2000 ETF
IWM
$80.8B
-4,000
Closed -$573K
IWM icon
315
PUT
iShares Russell 2000 ETF
IWM
$80.8B
-18,400
Closed -$2.63M
SPY icon
316
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$825B
-6,000
Closed -$1.85M
SPY icon
317
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$825B
-26,000
Closed -$8.02M

Similar funds

Dowling & Yahnke's Q3 2020 Portfolio in Review

As of Q3 2020, Dowling & Yahnke held 317 positions worth $1.25B, up 4.5% from $1.19B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Dowling & Yahnke's Q3 2020 filing shows 17 new, 127 increased, 146 reduced and 10 closed positions. Its largest new stake was Schrodinger: 9,828 shares worth $467K. The largest sale was DexCom, an estimated $14.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Dowling & Yahnke's largest Q3 2020 buy was Schrodinger: 9,828 shares worth $467K.
  • Dowling & Yahnke added most to Vanguard Emerging Markets Government Bond ETF in Q3 2020, an estimated $2.91M increase.
  • Dowling & Yahnke's biggest Q3 2020 reduction was DexCom, cutting an estimated $14.2M.
  • Dowling & Yahnke fully exited First Trust Enhanced Short Maturity ETF in Q3 2020, selling an estimated $580K.
  • Dowling & Yahnke's ten largest holdings make up 26% of its $1.25B portfolio in Q3 2020.
  • Dowling & Yahnke opened 17 new positions and closed 10 in Q3 2020.
  • Dowling & Yahnke's portfolio value rose 4.5% quarter-over-quarter to $1.25B.

Based on Dowling & Yahnke's 13F filing for Q3 2020, filed 19 Oct 2020.